SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001193125-23-058446
Filing Date
2023-03-03
Accepted
2023-03-02 18:13:58
Documents
2

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d379296dsc13da.htm SC 13D/A 37862
2 EX-1 d379296dex991.htm EX-99.1 75849
  Complete submission text file 0001193125-23-058446.txt   115258
Mailing Address 2430 N. HALSTED ST. CHICAGO IL 60614
Business Address 2430 N. HALSTED ST. CHICAGO IL 60614 847-673-1700
EXICURE, INC. (Subject) CIK: 0001698530 (see all company filings)

IRS No.: 815333008 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-90023 | Film No.: 23700780
SIC: 2834 Pharmaceutical Preparations

Mailing Address 3000 WESTERN AVENUE SUITE 400 SEATTLE WA 98121
Business Address 3000 WESTERN AVENUE SUITE 400 SEATTLE WA 98121 425-220-2542
CBI USA, Inc. (Filed by) CIK: 0001930189 (see all company filings)

IRS No.: 863703094 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A